Filing Details
- Accession Number:
- 0001209191-16-156552
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-22 16:53:16
- Reporting Period:
- 2016-12-20
- Filing Date:
- 2016-12-22
- Accepted Time:
- 2016-12-22 16:53:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1510580 | Kite Pharma Inc. | KITE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1610823 | Jeffrey Wiezorek | C/O Kite Pharma, Inc. 2225 Colorado Avenue Santa Monica CA 90404 | Svp Clinical Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-12-20 | 716 | $50.86 | 15,095 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.
Billionaire Hedge Funds
